Dáil Éireann Debate, Wednesday - 9 November 2022
110. Deputy Kieran O'Donnell asked the Minister for Health if the HSE plans to include the omnipod tubeless, wireless insulin patch pump on the list of approved insulin pumps that have been added to the insulin pump and transmitter pricing agreement. [55669/22]
View answerThe Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medical devices in the community drug schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013.
The HSE previously approached the manufacturer of the Omnipod tubeless, wireless insulin patch pump regarding making an application to be added to the list of approved Insulin pumps on the Insulin Pump and Transmitter Pricing Agreement. However, the company have not as yet availed of this opportunity.
